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doi:10.1016/j.asjsur.2011.11.006Summary Background/Objective: About 20% of biliary atresia (BA) survivors have attacks of
esophageal variceal bleeding. We propose a method to evaluate the risk of esophageal variceal
bleeding (EVB) using noninvasive indices by multislice computed tomography (CT).
Methods: We reviewed 31 potential living-related liver recipients aged 99e5314 days (mean,
1474 days) who underwent CT examinations using a 64-slice multislice CT scanner. Of the 31
patients, 19 patients (Group A) with fecal occult blood had EVB on esophagogastroduodeno-
scopy; the rest belonged to Group B. Splenic diameters (mm) were divided by body heights
(m) and platelet counts (1000/mm3) to produce standardized ratios of transverse splenic
length/body height/platelet count (SLHPR). The transverse diameters of paraesophageal veins
(PVs) and perigastric veins (PGVs) were measured adjacent to the lower thoracic esophagus
and within the lesser sac, respectively.
Results: According to a receiver operating characteristic curve analysis, the SLHPRs
(rZ 0.833), transverse PV (rZ 0.957), and PGV (rZ 0.987) diameters were better predictors
of EVB than demographic and laboratory variables. However, the transverse diameters of PGVs
and PVs were the most accurate predictors of the EVB.of Medical Imaging, Medical College and Hospital, National Taiwan University, 7 Chung-Shan South
w (S. Shinn-Forng Peng).
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CT to predict esophageal variceal bleeding 169Conclusion: For candidates awaiting liver transplantation, screening by noninvasive SLHPR and
the transverse diameters of PGVs and PVs by CT may help to identify BA patients with a high
risk of EVB.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Biliary atresia (BA), a potentially fetal fibro-obliterative
cholangiopathy, is the main indication of pediatric liver
transplantation.1e5 A Kasai operation is the procedure of
choice to re-establish bile flow in infants with BA.3e5
However, portal hypertension develops in about two-
thirds of long-term BA survivors regardless of the drainage
results of the Kasai operation.4e10
Variceal bleeding is the leading cause of severe gastro-
intestinal bleeding in children with BA, including those
candidates waiting for liver transplantation.11,12 Esoph-
agogastroduodenoscopy (EGD) is the current standard
diagnostic test for the detection of variceal bleeding, but
the decision to perform prophylactic EGD on all children
with BA is controversial.13e16 Predicting the presence of
esophageal variceal bleeding (EVB) using noninvasive indices
and criteria might increase the compliance of patients or
their families with testing and would restrict EGDs to
patients with a high probability of suffering from EVB.17
Noninvasive volume indices based on computed tomo-
graphic findings have been suggested for identifying EVB
risks of adults with hepatitis-related liver cirrhosis.18e21
Abdominal computed tomography (CT) is widely used for
volume measurements of the liver or spleen,22e24 and it has
become a standard item of the evaluation of all potential
candidates before orthotropic liver transplantation.22,23
The volume indices measured by CT, although easily per-
formed, are not equal to the true volumes of visceral organs
and are rarely applied to candidates of liver trans-
plantation. Correlations between CT volume indices and
the true volumes of the liver and spleen are scarce in the
literature. In addition, noninvasive CT indices and criteria,
including volume indices and measurements of para-
esophageal or gastroesophageal veins, have rarely been
suggested in the literature to evaluate BA patients,
including those awaiting liver transplantation. Further-
more, BA patients with EVB are usually older than those
without EVB, and patient age inevitably becomes a con-
founding variable.4,5,9,10 Here we propose a study of
noninvasive indices by measuring the diameters of the
spleen, caudate, left hepatic regions, adjusted to body
weight or body height and transverse diameters of para-
esophageal and gastroesophageal veins using a multislice
CT to evaluate the risk of EVB in BA patients prepared for
liver transplantation. Our hypotheses are: (a) the volume
indices of the spleen, caudate lobe, and left lobe of the
liver are correlated with each corresponding volume
measured by the region-of-interest (ROI) CT method, and
(b) noninvasive indices and transverse diameters of the
paraesophageal and gastroesophageal veins can predict the
EVB in patients with BA who are prepared for liver
transplantation.2. Materials and methods
2.1. Patient population
We retrospectively reviewed the cases of 31 patients with
BA after they underwent a Kasai operation between the
ages of 26 and 147 (60 24) days. The 31 patients (11 boys
and 20 girls) were 99e5314 days of age (mean, 1474 days)
when they received the CT examination as part of evalua-
tion of liver volume and vascular anatomies before liver
transplantation from January 2006 to September 2010. The
31 patients also had biliary complications (nZ 10) or portal
venous hypertension related to biliary cirrhosis (nZ 21)
between 33 and 5137 (2,011 1,652) days after Kasai por-
toenterostomy. The end points of the study were the time
of liver transplantation (nZ 18), the last visit (nZ 12), or
death before liver transplantation (nZ 1). Eighteen of the
31 patients subsequently received living-related liver
transplants 3e45 months after the CT examinations.
Another 12 of the 31 patients did not received liver trans-
plantation because they had improvement of biliary
complications (nZ 6) or variceal bleeding after endoscopic
variceal ligation (nZ 9). The other patient died of intrac-
table biliary tract infection and sepsis when awaiting liver
transplantation. The retrospective study was approved by
the committee of research ethics of National Taiwan
University Hospital (201010044R, www.cghjournal.org).
2.2. Criteria for EVB and ascites
A standard flexible endoscope (XP240 or XP260, Olympus,
Tokyo, Japan) was used for EGD examinations and was
performed in 21 patients, either before the CT examination
or no more than 2 months after the CT examinations. These
21 patients had clinical findings both related to gastroin-
testinal bleeding (including fecal occult blood) and clinical
signs related to portal hypertension (manifesting as
splenomegaly or pancytopenia). The remaining 10 patients
received at least one fecal occult blood examination and
were regularly monitored with examinations of stool occult
blood every 6 months after Kasai operation. These 10
patients did not have detectable occult blood in all fecal
examinations. In total, 21 patients underwent EGD exami-
nations, and 19 of the 21 patients had varices with red color
signs or active bleeding in the lower esophageal walls.
These 19 patients were classified as Group A, and the other
12 patients without EVB were classified as Group B. In
Group A, the indications of pretransplant evaluation were
portal hypertension (nZ 19). Nine of the Group A patients
received variceal ligation and did not received liver trans-
plantation because they remained stable during the regular
follow-up of 21 10 months after CT examination. In
170 C.-T. Yang et al.comparison, the Group B patients were indicated for pre-
transplant evaluation due to persistent jaundice after Kasai
operation (nZ 4) and recurrent cholangitis (nZ 8).2.3. CT imaging and image measurements
All CT scans were performed on a 64-slice multislice CT
scanner (Sensation 64, Siemens, Erlangen, Bavaria, Germany)
with kVP of 80e120, mA of 80e120, exposure time of 0.5
seconds, a 5-mm slice thickness without a gap, and a matrix
size of 512  512 within a field-of-view of 20e30 cm from
the diaphragmatic dome to the lower pole of the right
kidney. All CT images were typically obtained 30 and 80
seconds after starting a manual intravenous injection of
1 mL/kg nonionic contrast material (Ultravist 300, 300 mg/
mL iopromide, Schering AG, Berlin, Germany) to acquire
images during the arterial and portal venous phases.
Two radiologists interpreted all CT images to detect the
presence of EVB and provide consensus on the hepatic and
splenic indices and the measured diameters of the varices.
Paraesophageal veins (PVs) were defined as discrete,
enhanced tubular areas adjacent to the lower thoracic
esophagus. The largest short-axis diameter (mm) wasFigure 1 A 2476-day-old girl, with a body weight of 25 kg and a he
(A) Computed tomography through the hepatic dome reveals eng
varices are also engorged within the lesser sac (arrowheads). T
respectively; (C) in the coronal plane through the splenic hilum,
(mm)/body height (m)/platelet count (1000/mm3) is 1.69 and the
(1000/mm3) ratio is 0.93; (D) there are several varices (arrows) disc
wall.measured according to previously described methods.25,26
The largest short-axis diameters (mm) of the perigastric
veins (PGVs) were also measured near the outer aspects of
the gastric walls within the lesser sacs.
The liver was divided into the left and right lobes and
the caudate region. The lateral border of the caudate
region was defined as an imaginary line connecting the
bifurcation of the main portal vein and the right lateral
border of the inferior vena cava. The measurements of the
lengths or long and short axes (cm) of the left lobe, caudate
hepatic region and the spleen were obtained from axial CT
images according to previously described methods.21,27 On
the coronal CT images, we measured the maximal cepha-
locaudal height (cm) of the spleen, left lobe, and caudate
region of the liver. Measurements of all three axial lengths
of the hepatic regions and spleen were typically made
within 1 cm of the level of the left umbilical portal vein and
splenic hilum, respectively (Fig. 1). Volume indices were
calculated as a simple product of three diameters (cm) for
the spleen and each region of the liver as described by Ito
and colleagues.21
The volumes of the left lobe, caudate region, and spleen
were also estimated by summation of serially traced ROI
areas drawn by hand on the axial images.28 However, theight of 1.20 m, has recurrent cholangitis and fecal occult blood.
orged paraesophageal varices (arrowhead); (B) the perigastric
he transverse splenic length and width are 123 and 79 mm,
the splenic height is 147 mm. The transverse splenic length
splenic volume index (mm3)/body weight (kg)/platelet count
losed by esophagogastroduodenoscopy on the lower esophageal
CT to predict esophageal variceal bleeding 171splenic length, indices, and ROI volumes were not obtained
in two Group A patients who had received a splenectomy
prior to the CT exam.
2.4. Less-invasive indices
To include body height in our evaluation, the splenic length
and the transverse splenic length (mm)/platelet count
(1000/mm3) ratios (SLPR) were divided by each patient’s
body height (m) to produce standardized indices. In addi-
tion, the splenic volume index (mm3)/platelet count (1000/
mm3) ratio (SVIPR), the volume index of the caudate lobe/
albumin-level ratio and the volume index of the left
hepatic lobe/albumin-level ratio were each divided by the
patient’s body weight (kg) to produce the corresponding
standardized ratio indices. In total, we chose one
measurement and nine calculated ratio indices to correlate
with the presence of EVB, including the transverse length
of the spleen (mm), transverse length of spleen (mm)/body
height (m), SLPR, transverse splenic length (mm)/body
height (m)/platelet count (1000/mm3) (SLHPR), SVIPR, the
splenic volume index (mm3)/body weight (kg)/platelet
count (1000/mm3) ratio (SVWPR), the volume index of the
caudate lobe (mm3)/albumin level (g/dL) ratio, the volume
index of the caudate lobe (mm3)/body weight (kg)/albumin
level (g/dL) ratio, the volume index of the left hepatic
lobe/albumin level (mg/dL) ratio, and the volume index of
the left hepatic lobe/body weight (kg)/albumin level (mg/
dL) ratio.
2.5. Statistical analysis
All data were analyzed using the STATA 8.0 software
package (Stata, College Station, Texas, USA), and a p value
<0.05 was considered statistically significant. Analyses of
the biochemical data, CTP scores, PELD/MELD scores,
image measurements, and ratio indices, as well as the
analysis of ordinal data such as age and score results, were
performed using a Mann-Whitney rank-sum test. Sex, age,
CTP classification, presence of encephalopathy and pres-
ence of ascites were compared between groups by a Chi-
squared test. Volume indices were correlated with ROI
volumes and tested by a Spearman rank test (p< 0.05 was
considered statistically significant). Sensitivity and speci-
ficity, as well as the best cutoff values for age, image
measurements, and index ratios to predict the presence of
EVB were calculated using receiver operating characteristic
(ROC) curves. An area under the ROC curve of more than 0.7
was considered a fairly predictive value, 0.8 was consid-
ered good, and greater than 0.9 was excellent. Sensitivity,
specificity, negative, and positive predictive values and
likelihood ratios were calculated for different cutoff
points.
3. Results
The Group A patients (1968 1857; 163e5,314 days) were
significantly older (p< 0.01) than the Group B (436 800;
137e2950 days) patients (Table 1). Group A patients
(21.8 17.2 kg and 1.02 0.42 m) were also significantly
heavier (pZ 0.04) and taller (pZ 0.01) than the Group Bpatients (7.1 3.3 kg and 0.66 0.16 m). In addition,
Group A patients (3.58 0.44 g/dL and 176 154 k/mm3)
had significantly decreased albumin levels (pZ 0.01) and
platelet counts (p< 0.01) compared with Group B patients
(3.95 0.32 g/dL and 309 156 k/mm3). Otherwise, there
were no significant differences (p> 0.05) between Group A
and Group B patients for other demographic data and
laboratory findings, including the age (when the Kasai
operation was performed), sex, Child-Turcotte-Pugh
scores, bilirubin, presence of ascites, presence of enceph-
alopathy, and pediatric end-stage liver disease (PELD)/
model of end-stage liver disease (MELD) scores (Table 1). In
Group A, the PELD/MELD scores were not significantly
different between those received and did not receive
living-related liver transplant (pZ 0.99).
Group A patients had significantly (p< 0.01) prominent
PGVs and PVs (1.11 2.54 mm and 0.96 2.09 mm)
compared with Group B patients (0.34 0.65 mm and
0.32 0.60 mm). In addition, ROI volumes and the volume
indices of the caudate (rZ 0.915) and left hepatic regions
(rZ 0.867) were significantly correlated (p< 0.01 for
both). The splenic ROI volume and volume indices were also
significantly correlated (rZ 0.965, p< 0.01). There were
no significant differences in the volume indices of the
caudate regions (58 69 mm3 vs 105 273 mm3) or the left
hepatic lobes (1860 5559 mm3 vs. 385 226 mm3) of the
Group A and B patients (p> 0.05). This is shown in Table 1.
However, Group B patients (69.3 18.9 mm) had a signifi-
cantly shorter (p< 0.01) transverse length of the spleen
than Group A (100.3 31.6 mm). Additionally, Group A
patients (930 1044 mm3) had a significantly larger
(p< 0.01) splenic volume index than Group B
(223 126 mm3).
The splenic indices were well correlated with the pres-
ence of varices. Group A patients (1.231 1.199 and
15.489 27.284) had significantly larger (p< 0.01) SLPRs
and SVIPRs than Group B patients (0.288 0.152 and
1.019 0.810). Furthermore, the standardized ratios,
SLHPR and SVWPR, were also significantly larger (p< 0.01)
in Group A patients (1.089 0.700 and 0.522 0.556 vs.
0.430 0.214 and 0.129 0.081, respectively).
ROC analysis showed that the transverse diameters of
the PGVs (with a cutoff value of 2.6 mm) and PVs (cutoff
value, 2.8 mm) had excellent (under-the-curve areas of
0.987 and 0.957, respectively) sensitivity (92% and 96%,
respectively) and specificity (100% for both). This is shown
in Table 2. In addition, SLHPR showed a good predictive
value and a good sensitivity (87%), and a fair specificity
(66.7%) could be obtained if a cutoff value of 0.454 was
used. By contrast, variables such as age, body weight, body
height, and SVWPR had only fair predictive values (Table 2).
Albumin level and platelet count had small areas under the
ROC curve.4. Discussion
Even after receiving successful corrective surgery, EVB is
a serious complication of portal hypertension and is found
in 20%e50% of long-term BA survivors, including candidates
awaiting liver transplantation.4e7,9,12,29e32 In children with
BA-related biliary cirrhosis, esophageal varices usually
Table 1 Comparison of demographic, laboratory data, Child-Turcotte-Pugh, pediatric end-stage liver disease or model of end-
stage liver disease scores, splenic length, splenic and hepatic indices of patients with biliary atresia with and without esoph-
ageal variceal bleeding.
Esophageal variceal bleeding p value
(þ) (e)
Sex
Boys 5 6 0.18
Girls 14 6
Age (d) of CT examination 2147 1866 (163e5314) 436 800 (137e2950) < 0.01*
Age (d) of Kasai operation 62 27 64 25 0.06
Body weight at CT examination (kg) 23.6 17.9 7.1 3.3 < 0.01*
Body height at CT examination (m) 1.06 0.42 0.66 0.16 < 0.01*
Bilirubin (g/dl) 9.5 3.0 9.8 3.9 0.71
Albumin (g/dl) 3.65 0.40 3.95 0.32 0.03*
Platelet count (k/mm3) 176 154 309 156 < 0.01*
Child-Turcotte-Pugh score 7 2 8 1 1.0
PELD or MELD score 12 9 13 12 0.67
Diameter of gastroesophageal varices (mm) 1.11 2.54 0.34 0.65 < 0.01 *
Diameter of paraesophageal varices (mm) 0.96 2.09 0.32 0.60 < 0.01 *
Length of spleen (mm) 100.3 31.6 69.3 18.9 < 0.01 *
Length of spleen (mm)/body height (m) 112 22 107 31 0.53
SLPR 1.231 1.199 0.288 0.152 < 0.01 *
SLHPR 1.089 0.700 0.430 0.214 < 0.01 *
Splenic volume index (mm3) 930 1044 223 126 < 0.01 *
SVIPR 15.489 27.284 1.019 0.810 < 0.01 *
SVWPR 0.522 0.556 0.129 0.081 < 0.01 *
Volume index of caudate segment (mm3) 58 69 105 273 0.74
Volume index of caudate segment/albumin level 15.46 17.54 26.40 68.20 0.58
0.80 0.65 4.33 11.70 0.31
Volume index of left hepatic lobe (mm3) 1860 5559 385 226 0.16
Volume index of left hepatic lobe/albumin level 575.35 1854.62 98.88 58.00 0.12
69.30 292.46 13.36 4.98 0.34
CTZ computed tomography; CVIWARZ volume index of caudate segment (mm3)/albumin level (g/dl)/(body weight) (g); LVI-
WARZ volume index of left hepatic lobe(mm3)/albumin level (g/dl)/(body weight) (g); MELDZmodel of end-stage liver disease;
PELDZ pediatric end-stage liver disease; SLHPRZ transverse splenic length (mm)/body height (m)/platelet count (1000/mm3);
SLPRZ transverse length of spleen (mm)/platelet count (1000/mm3); SVIPRZ splenic volume index (mm3)/platelet count (1000/mm3);
SVWPRZ the splenic volume index (mm3)/body weight (g)/platelet count (1000/mm3) ratio.
* Z p < 0.05.
172 C.-T. Yang et al.develop at as early as 2 years of age.8 In our series, a 6-
month-old girl had EVB and fecal occult blood. Early
detection of esophageal varices and subsequent endoscopicTable 2 ROC of age, body habitus, albumin level, platelet coun
on computed tomography and splenic indices to detect esophage
Noninvasive index Cutoff value
Age (d) 184
Body weight (kg) 6.0
Body height (m) 0.60
Albumin (mg/dl) 4.38
Platelet count (1000/mm3) 40.5
Diameter of gastroesophageal varices (mm) 2.6
Diameter of paraesophageal varices (mm) 2.8
SLHPR 0.454
SVWPR 0.058
ROCZ receiver operating characteristic; SLHPRZ transverse splen
SVWPRZ the splenic volume index (mm3)/body weight (g)/platelet ctreatment usually prevent bleeding during the period
awaiting suitable liver donors and avoid emergent liver
transplantation that is associated with significantt, and diameters of gastroesophageal, paraesophageal varices









0.772 91.3% 50.0% 77.9%
0.772 91.3% 50.0% 77.9%
0.736 91.3% 41.7% 75.2%
0.250 4% 91.7% 32.4%
0.178 95.7% 0% 64.7%
0.987 96.0% 100% 97.3%
0.957 92.0% 100% 94.6%
0.833 87.0% 66.7% 80.4%
0.790 100% 25% 75.7%
ic length (mm)/body height (m)/platelet count (1,000/mm3);
ount (1000/mm3) ratio.
CT to predict esophageal variceal bleeding 173perioperative risks.8,32 After adequate management of EVB,
those patients with total serum bilirubin concentration
4 mg/dL may await suitable liver graft for 4 years after
the episode of EVB.7 However, screening EGDs for children
are expensive, time-consuming, and require adequate
anesthesia.33e36 In addition, a properly sized endoscope is
not always available, especially for infants.36 Thus, EGD is
not usually suggested for BA children or infants until the
first occurrence of gastrointestinal bleeding, unlike adults
with hepatitis-related cirrhosis.12,16,36 Consequently,
noninvasive indices from pretransplant CT can help to
identify high-risk BA patients and suggest EGD studies for
the early detection and intervention of EVB.
Noninvasive criteria, including volume indices, have
been widely used to predict EVB in adults with hepatitis-
related liver cirrhosis,18e21 but they have been rarely
applied to pediatric patients. CT is widely accepted to be
efficient modality to evaluate graft volumes and hepatic
vascular anatomy before liver transplantation.37,38 CT has
sufficient spatial resolution and is considered a reliable
method for assessing the hepatic and splenic volume
and/or the volume of other intra-abdominal organs
in vivo.22e24,31,39,40 Previous studies have assumed visceral
organs to be ellipsoid in shape and have proposed volume
indices to provide estimates of organ size.21 However,
volume indices have rarely been correlated with the true
volume of visceral organs to date. According our results,
the correlations between volume indices and the volumes
measured by the ROI method were moderate (r> 0.8) and
significant (p< 0.01) in the liver and spleen. Volume indices
are thus an easy and reliable method for estimating hepatic
or splenic volumes, even in pediatric patients.
Hepatic and splenic volumes increase with patient
age.41,42 BA patients with EVB are usually older than those
without EVB,3e7,9 and their visceral organ sizes are deter-
mined by body status and affected by age.41,42 The Group A
patients were significantly older than Group B without EVB.
Group B patients had a significantly shorter splenic trans-
verse length (p< 0.01) and smaller splenic indices (p< 0.01)
than Group A. Initially, it was difficult to exclude the con-
founding effects of age on the difference of splenic trans-
verse length and splenic indices between the Group A and
Group B patients. The volume indices normalized to body
weight and the splenic length/body-height ratios compen-
sated for the confounding variables, including age, body
weight, and body height, to yield standardized ratios allow-
ing for comparisons of pediatric patients amongdifferent age
groups. According to the results of our ROC analysis, the
noninvasive indices of standardized SVWPR and SLHPR had
larger areas under the ROC curves and predicted the pres-
ence of EVB better than other laboratory or demographic
findings. Unlike in previous studies of volume indices applied
to cirrhotic adults, standardized indices including SVWPRand
SLHPR are more preferred than demographic or laboratory
findings in pediatric BA patients.
Various collateral blood vessels develop in cirrhotic
patientswithportal hypertension.29,43 PGVsandPVsaremore
directly related to portal venous congestion than splenic and
retroperitoneal varices.29,43 Previous reports of adults with
liver cirrhosis suggest that themeasurementof the transverse
diameters of PGVs and PVs can be used to predict the pres-
ence of EVB,29,44e46 but similar studies in BA patients arescarce in the literature. In addition, the studies of cirrhotic
adult populations rarely compare measurements of the
transverse diameters of varices with noninvasive hepatic or
splenic indices to predict the presence of EVB. According to
our results, the transverse diameters of PGVs and PVs were
highly accurate predictors of the presence of clinically
evident EVB. Our ROC analysis suggested that the transverse
diameters of PGVs and PVs had larger areas under the ROC
curve and were more reliable for predicting the presence of
EVB than other noninvasive splenic indices or laboratory or
demographic criteria. In children, measuring PGVs and PVs is
more feasible by CT than ultrasonography.47 Thus, where
feasible, measurements of the transverse diameter of PGVs
andPVs are suggestedwhen long-term survivors of BA receive
multislice abdominal CT examinations.
The limitations of this study include infrequent EGD
examinations in patients younger than 2 years of age.
Therefore, the prevalence of EVB in these younger patients
can be underestimated. In addition, the study uses
a retrospective design and a small sample size. Further
prospective studies of large sample sizes may refine and
confirm the reliability of these noninvasive criteria and
indices when applied to long-term survivors of BA.
5. Conclusion
Screening with noninvasive SLHPR and measurement of the
transverse diameters of PGVs and PVs by CT may help to
identify BA patients carrying a high risk of developing EVB
and suggests a more aggressive use of endoscopic inter-
vention in candidates waiting for liver transplantation.
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